Comparison of health-related quality of life among men with different co-existing severe mental disorders in treatment for substance use

Table 2 Comparison of clinical measures among men in treatment for substance use disorder patients by type of severe mental illness

Clinical measures	Substance use disorder groups with comorbid severe mental illness
Clinical measures	Schizophrenia (n = 37)		Bipolar disorder (n = 34)	Major depressive disorder (n = 36)	ANOVA
DAST-20 total score	12.06 ± 0.42		11.20 ± 1.22	14.13 ± 0.65	F ₍₂₁₀₅₎ = 3.331
PANSS	Direct scores	Percentile scores
Positive symptoms	10.63 ± 1.21	5
Negative symptoms	13.32 ± 1.65	15
Composite Score	−2.69 ± 3.97	40
General Psychopathology	28.72 ± 2.80	10
HDRS total score			7.73 ± 0.60	12.18 ± 0.91	F _(1,68) = 6.315*
YMRS total score			2.08 ± 0.57

DAST-20: Drug Abuse Screening Test; PANSS: Positive and Negative Syndrome Scale: HDRS: Hamilton Depression Rating Scale; YMRS: Young Mania Rating Scale
*p < 0.05; **p ≤ 0.01; ***p ≤ 0.001

ISSN: 1477-7525